Identification and SAR for a selective, nonpeptidyl thrombin inhibitor. 1998

A M Naylor-Olsen, and G S Ponticello, and S D Lewis, and A M Mulichak, and Z Chen, and C N Habecker, and B T Phillips, and W M Sanders, and T J Tucker, and J A Shafer, and J P Vacca
Department of Molecular Design and Diversity, Merck Research Laboratories, West Point, PA 19486, USA.

A novel, nonpeptidyl thrombin inhibitor, L-636,619 (1), was identified via topological similarity searching over the Merck Corporate Sample Database. X-ray crystallographic studies determined the geometry for ligand binding to the enzyme. Chemical modification of the P1 and P3 segments of the ligand resulted in enhanced potency and improvement in the chemical stability of the lead. Analog 9 proved to be the most interesting lead from this structurally novel series.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D003461 Crystallography The branch of science that deals with the geometric description of crystals and their internal arrangement. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Crystallographies
D000991 Antithrombins Endogenous factors and drugs that directly inhibit the action of THROMBIN, usually by blocking its enzymatic activity. They are distinguished from INDIRECT THROMBIN INHIBITORS, such as HEPARIN, which act by enhancing the inhibitory effects of antithrombins. Antithrombin,Direct Antithrombin,Direct Antithrombins,Direct Thrombin Inhibitor,Direct Thrombin Inhibitors,Antithrombin, Direct,Antithrombins, Direct,Inhibitor, Direct Thrombin,Thrombin Inhibitor, Direct,Thrombin Inhibitors, Direct
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

A M Naylor-Olsen, and G S Ponticello, and S D Lewis, and A M Mulichak, and Z Chen, and C N Habecker, and B T Phillips, and W M Sanders, and T J Tucker, and J A Shafer, and J P Vacca
July 1997, Protein science : a publication of the Protein Society,
A M Naylor-Olsen, and G S Ponticello, and S D Lewis, and A M Mulichak, and Z Chen, and C N Habecker, and B T Phillips, and W M Sanders, and T J Tucker, and J A Shafer, and J P Vacca
March 2001, Biochemical and biophysical research communications,
A M Naylor-Olsen, and G S Ponticello, and S D Lewis, and A M Mulichak, and Z Chen, and C N Habecker, and B T Phillips, and W M Sanders, and T J Tucker, and J A Shafer, and J P Vacca
April 2004, Bioorganic & medicinal chemistry,
A M Naylor-Olsen, and G S Ponticello, and S D Lewis, and A M Mulichak, and Z Chen, and C N Habecker, and B T Phillips, and W M Sanders, and T J Tucker, and J A Shafer, and J P Vacca
June 1997, Biochemical and biophysical research communications,
A M Naylor-Olsen, and G S Ponticello, and S D Lewis, and A M Mulichak, and Z Chen, and C N Habecker, and B T Phillips, and W M Sanders, and T J Tucker, and J A Shafer, and J P Vacca
August 2001, Bioorganic & medicinal chemistry letters,
A M Naylor-Olsen, and G S Ponticello, and S D Lewis, and A M Mulichak, and Z Chen, and C N Habecker, and B T Phillips, and W M Sanders, and T J Tucker, and J A Shafer, and J P Vacca
January 2005, Experimental hematology,
A M Naylor-Olsen, and G S Ponticello, and S D Lewis, and A M Mulichak, and Z Chen, and C N Habecker, and B T Phillips, and W M Sanders, and T J Tucker, and J A Shafer, and J P Vacca
May 2011, Bioorganic & medicinal chemistry letters,
A M Naylor-Olsen, and G S Ponticello, and S D Lewis, and A M Mulichak, and Z Chen, and C N Habecker, and B T Phillips, and W M Sanders, and T J Tucker, and J A Shafer, and J P Vacca
October 1996, Masui. The Japanese journal of anesthesiology,
A M Naylor-Olsen, and G S Ponticello, and S D Lewis, and A M Mulichak, and Z Chen, and C N Habecker, and B T Phillips, and W M Sanders, and T J Tucker, and J A Shafer, and J P Vacca
November 2020, European journal of medicinal chemistry,
A M Naylor-Olsen, and G S Ponticello, and S D Lewis, and A M Mulichak, and Z Chen, and C N Habecker, and B T Phillips, and W M Sanders, and T J Tucker, and J A Shafer, and J P Vacca
August 2001, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!